Immune Responses and Viral Persistence in Simian/Human Immunodeficiency Virus SHIV.C.CH848-Infected Rhesus Macaques. 2021

Widade Ziani, and Anya Bauer, and Hong Lu, and Xiaolei Wang, and Xueling Wu, and Katharine J Bar, and Hui Li, and Dongfang Liu, and George M Shaw, and Ronald S Veazey, and Huanbin Xu
Tulane National Primate Research Center, Tulane University School of Medicine, Covington, Louisiana, USA.

Chimeric simian/human immunodeficiency viruses (SHIVs) are widely used in nonhuman primate models to recapitulate human immunodeficiency virus (HIV) infection in humans, yet most SHIVs fail to establish persistent viral infection. We investigated immunological and virological events in rhesus macaques infected with the newly developed SHIV.C.CH848 (SHIVC) and treated with combined antiretroviral therapy (cART). Similar to HIV/simian immunodeficiency virus (SIV) infection, SHIV.C.CH848 infection established viral reservoirs in CD4+ T cells and myeloid cells, accompanied by productive infection and depletion of CD4+ T cells in systemic and lymphoid tissues throughout SHIV infection. Despite 6 months of cART-suppressed viral replication, integrated proviral DNA levels remained stable, especially in CD4+ T cells, and the viral rebound was also observed after ART interruption. Autologous neutralizing antibodies to the parental HIV-1 strain CH848 were detected, with limited viral evolution at 5 months postinfection. In comparison, heterogenous neutralizing antibodies in SHIV.C.CH848-infected macaques were not detected except for 1 (1 of 10) animal at 2 years postinfection. These findings suggest that SHIV.C.CH848, a novel class of transmitted/founder SHIVs, can establish sustained viremia and viral reservoirs in rhesus macaques with clinical immunodeficiency consequences, providing a valuable SHIV model for HIV research.IMPORTANCE SHIVs have been extensively used in a nonhuman primate (NHP) model for HIV research. In this study, we investigated viral reservoirs in tissues and immune responses in an NHP model inoculated with newly generated transmitted/founder HIV-1 clade C-based SHIV.C.CH848. The data show that transmitted founder (T/F) SHIVC infection of macaques more closely recapitulates the virological and clinical features of HIV infection, including persistent viremia and viral rebound once antiretroviral therapy is discontinued. These results suggest this CCR5-tropic, SHIVC strain is valuable for testing responses to HIV vaccines and therapeutics.

UI MeSH Term Description Entries
D008253 Macaca mulatta A species of the genus MACACA inhabiting India, China, and other parts of Asia. The species is used extensively in biomedical research and adapts very well to living with humans. Chinese Rhesus Macaques,Macaca mulatta lasiota,Monkey, Rhesus,Rhesus Monkey,Rhesus Macaque,Chinese Rhesus Macaque,Macaca mulatta lasiotas,Macaque, Rhesus,Rhesus Macaque, Chinese,Rhesus Macaques,Rhesus Macaques, Chinese,Rhesus Monkeys
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014766 Viremia The presence of viruses in the blood. Viremias
D015302 Simian Immunodeficiency Virus Species of the genus LENTIVIRUS, subgenus primate immunodeficiency viruses (IMMUNODEFICIENCY VIRUSES, PRIMATE), that induces acquired immunodeficiency syndrome in monkeys and apes (SAIDS). The genetic organization of SIV is virtually identical to HIV. SIV (Simian immunodeficiency virus),Immunodeficiency Viruses, Simian,Simian Immunodeficiency Viruses,Immunodeficiency Virus, Simian
D015496 CD4-Positive T-Lymphocytes A critical subpopulation of T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the T4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes. T4 Cells,T4 Lymphocytes,CD4-Positive Lymphocytes,CD4 Positive T Lymphocytes,CD4-Positive Lymphocyte,CD4-Positive T-Lymphocyte,Lymphocyte, CD4-Positive,Lymphocytes, CD4-Positive,T-Lymphocyte, CD4-Positive,T-Lymphocytes, CD4-Positive,T4 Cell,T4 Lymphocyte
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D016097 Simian Acquired Immunodeficiency Syndrome Acquired defect of cellular immunity that occurs naturally in macaques infected with SRV serotypes, experimentally in monkeys inoculated with SRV or MASON-PFIZER MONKEY VIRUS; (MPMV), or in monkeys infected with SIMIAN IMMUNODEFICIENCY VIRUS. AIDS, Simian,SAIDS,Simian AIDS,Simian Acquired Immune Deficiency Syndrome,Simian Acquired Immuno-Deficiency Syndrome,AIDSs, Simian,Simian AIDSs,Simian Acquired Immuno Deficiency Syndrome

Related Publications

Widade Ziani, and Anya Bauer, and Hong Lu, and Xiaolei Wang, and Xueling Wu, and Katharine J Bar, and Hui Li, and Dongfang Liu, and George M Shaw, and Ronald S Veazey, and Huanbin Xu
January 1994, Journal of medical primatology,
Widade Ziani, and Anya Bauer, and Hong Lu, and Xiaolei Wang, and Xueling Wu, and Katharine J Bar, and Hui Li, and Dongfang Liu, and George M Shaw, and Ronald S Veazey, and Huanbin Xu
October 2004, Journal of virology,
Widade Ziani, and Anya Bauer, and Hong Lu, and Xiaolei Wang, and Xueling Wu, and Katharine J Bar, and Hui Li, and Dongfang Liu, and George M Shaw, and Ronald S Veazey, and Huanbin Xu
September 2000, Veterinary pathology,
Widade Ziani, and Anya Bauer, and Hong Lu, and Xiaolei Wang, and Xueling Wu, and Katharine J Bar, and Hui Li, and Dongfang Liu, and George M Shaw, and Ronald S Veazey, and Huanbin Xu
May 2002, International journal for parasitology,
Widade Ziani, and Anya Bauer, and Hong Lu, and Xiaolei Wang, and Xueling Wu, and Katharine J Bar, and Hui Li, and Dongfang Liu, and George M Shaw, and Ronald S Veazey, and Huanbin Xu
July 1995, Journal of virology,
Widade Ziani, and Anya Bauer, and Hong Lu, and Xiaolei Wang, and Xueling Wu, and Katharine J Bar, and Hui Li, and Dongfang Liu, and George M Shaw, and Ronald S Veazey, and Huanbin Xu
June 2007, Journal of virology,
Widade Ziani, and Anya Bauer, and Hong Lu, and Xiaolei Wang, and Xueling Wu, and Katharine J Bar, and Hui Li, and Dongfang Liu, and George M Shaw, and Ronald S Veazey, and Huanbin Xu
January 2019, Frontiers in microbiology,
Widade Ziani, and Anya Bauer, and Hong Lu, and Xiaolei Wang, and Xueling Wu, and Katharine J Bar, and Hui Li, and Dongfang Liu, and George M Shaw, and Ronald S Veazey, and Huanbin Xu
December 2023, Vaccines,
Widade Ziani, and Anya Bauer, and Hong Lu, and Xiaolei Wang, and Xueling Wu, and Katharine J Bar, and Hui Li, and Dongfang Liu, and George M Shaw, and Ronald S Veazey, and Huanbin Xu
March 1995, AIDS research and human retroviruses,
Widade Ziani, and Anya Bauer, and Hong Lu, and Xiaolei Wang, and Xueling Wu, and Katharine J Bar, and Hui Li, and Dongfang Liu, and George M Shaw, and Ronald S Veazey, and Huanbin Xu
November 1996, Journal of virology,
Copied contents to your clipboard!